Dimethyl biphenyl-4,4'-dicarboxylate

Dimethyl biphenyl-4,4'-dicarboxylate (CAS No.: 792-74-5) is a bioactive small molecule originally derived from traditional medicinal sources and widely utilized as a hepatoprotective agent in biomedical research, particularly in studies of liver injury and chronic hepatitis. It exerts its biological effects primarily through modulation of interferon-related signaling pathways, notably activating the JAK/STAT cascade and inducing the expression of interferon-α–stimulated genes such as ISG12 and related antiviral effectors, thereby influencing inflammatory responses, viral replication processes, and fibrotic progression in hepatic tissues. Experimental evidence indicates that this compound can inhibit the replication of viral pregenomic RNA and reduce associated antigen expression, supporting its relevance in hepatitis B research models. In vitro studies, including those using hepatocyte-derived cell lines, have demonstrated pathway activation and gene induction at micromolar concentration ranges, although effective concentrations may vary depending on the cellular context and assay design. Dimethyl biphenyl-4,4'-dicarboxylate is frequently employed in cell-based and preclinical models to investigate mechanisms of hepatocellular protection, interferon signaling, and antiviral responses, and it has also been explored as a payload in drug delivery systems such as polymeric micelles. Its applications extend to drug discovery and pharmacological studies focused on liver diseases, where experimental dosing and formulation strategies are adapted according to specific research objectives.